HEADER TRANSCRIPTION/TRANSCRIPTION INHIBITOR 30-NOV-21 7T0S TITLE CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN IN COMPLEX WITH OICR-11864 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM 2 OF B-CELL LYMPHOMA 6 PROTEIN; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: BCL-6,B-CELL LYMPHOMA 5 PROTEIN,BCL-5,PROTEIN LAZ-3,ZINC COMPND 5 FINGER AND BTB DOMAIN-CONTAINING PROTEIN 27,ZINC FINGER PROTEIN 51; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL6, BCL5, LAZ3, ZBTB27, ZNF51; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS IMMUNITY, INFLAMMATORY RESPONSE, TRANSCRIPTION REPRESSOR, KEYWDS 2 TRANSCRIPTION-TRANSCRIPTION INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.A.KUNTZ,G.G.PRIVE REVDAT 2 25-OCT-23 7T0S 1 REMARK REVDAT 1 14-DEC-22 7T0S 0 JRNL AUTH D.A.KUNTZ,G.G.PRIVE JRNL TITL CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN IN COMPLEX WITH JRNL TITL 2 OICR-11864 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 29231 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.710 REMARK 3 FREE R VALUE TEST SET COUNT : 1377 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.7800 - 4.0000 0.99 2825 146 0.2158 0.2701 REMARK 3 2 3.9900 - 3.1700 1.00 2810 130 0.1856 0.2151 REMARK 3 3 3.1700 - 2.7700 1.00 2788 139 0.2020 0.2431 REMARK 3 4 2.7700 - 2.5200 1.00 2777 153 0.2075 0.2432 REMARK 3 5 2.5200 - 2.3400 0.99 2767 142 0.2019 0.2399 REMARK 3 6 2.3400 - 2.2000 1.00 2782 142 0.2037 0.2329 REMARK 3 7 2.2000 - 2.0900 1.00 2797 123 0.2227 0.2524 REMARK 3 8 2.0900 - 2.0000 0.99 2755 125 0.2374 0.2474 REMARK 3 9 2.0000 - 1.9200 1.00 2806 148 0.2671 0.2940 REMARK 3 10 1.9200 - 1.8600 0.99 2747 129 0.3016 0.3341 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.890 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3184 REMARK 3 ANGLE : 1.054 4327 REMARK 3 CHIRALITY : 0.065 496 REMARK 3 PLANARITY : 0.011 533 REMARK 3 DIHEDRAL : 16.041 1166 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7T0S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-DEC-21. REMARK 100 THE DEPOSITION ID IS D_1000261396. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29330 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.856 REMARK 200 RESOLUTION RANGE LOW (A) : 55.869 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.70900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1R29 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 21% PEG6K AS PRECIPITANT IN PH 6.6 REMARK 280 CACODYLATE 10% DMSO +100 MM AMSO4 CRYSTAL CRYOPROTECTED IN REMARK 280 RESEVOIR BUFFER CONTAINING 25% GLYCEROL, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 46.37000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.14500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 46.37000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.14500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -17.39154 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 52.52564 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4270 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 319 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 332 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 3 REMARK 465 SER A 4 REMARK 465 ALA A 5 REMARK 465 ASP A 6 REMARK 465 GLU A 129 REMARK 465 GLY B 3 REMARK 465 SER B 4 REMARK 465 ALA B 5 REMARK 465 ASP B 6 REMARK 465 GLU B 129 REMARK 465 GLY C 3 REMARK 465 SER C 4 REMARK 465 ALA C 5 REMARK 465 ASP C 6 REMARK 465 GLU C 129 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 40 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 98 CD NE CZ NH1 NH2 REMARK 470 GLU A 99 CG CD OE1 OE2 REMARK 470 SER A 128 OG REMARK 470 ARG B 13 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 64 CD OE1 NE2 REMARK 470 GLN C 64 CG CD OE1 NE2 REMARK 470 ARG C 94 NE CZ NH1 NH2 REMARK 470 GLU C 99 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 8 41.81 -150.43 REMARK 500 SER A 39 -120.80 69.02 REMARK 500 ASN A 101 -15.35 -141.12 REMARK 500 MET A 114 73.82 -102.46 REMARK 500 ALA A 127 51.92 -145.31 REMARK 500 GLN B 8 85.38 -69.13 REMARK 500 SER B 39 -112.66 53.92 REMARK 500 MET B 114 79.95 -109.03 REMARK 500 SER C 39 -112.62 63.87 REMARK 500 MET C 114 76.49 -102.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7LWE RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-7629 REMARK 900 RELATED ID: 7LWF RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-9320 REMARK 900 RELATED ID: 7LWG RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-12694 REMARK 900 RELATED ID: 7LZQ RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-4425 REMARK 900 RELATED ID: 7LZS RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-11029 REMARK 900 RELATED ID: 7RUW RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-7859 REMARK 900 RELATED ID: 7RUX RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-8311 REMARK 900 RELATED ID: 7RUY RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-8388 REMARK 900 RELATED ID: 7RUZ RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-8445 REMARK 900 RELATED ID: 7RV0 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-8446 REMARK 900 RELATED ID: 7RV1 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-8826 REMARK 900 RELATED ID: 7RV2 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-8828 REMARK 900 RELATED ID: 7RV3 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-9124 REMARK 900 RELATED ID: 7RV4 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-9153 REMARK 900 RELATED ID: 7RV5 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-9287 REMARK 900 RELATED ID: 7RV6 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-9288 REMARK 900 RELATED ID: 7RV7 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-9322 REMARK 900 RELATED ID: 7RV8 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-10268 REMARK 900 RELATED ID: 7RV9 RELATED DB: PDB REMARK 900 BCL6_BTB WITH OICR-10269 DBREF 7T0S A 5 129 UNP P41182 BCL6_HUMAN 5 129 DBREF 7T0S B 5 129 UNP P41182 BCL6_HUMAN 5 129 DBREF 7T0S C 5 129 UNP P41182 BCL6_HUMAN 5 129 SEQADV 7T0S GLY A 3 UNP P41182 EXPRESSION TAG SEQADV 7T0S SER A 4 UNP P41182 EXPRESSION TAG SEQADV 7T0S GLN A 8 UNP P41182 CYS 8 ENGINEERED MUTATION SEQADV 7T0S ARG A 67 UNP P41182 CYS 67 ENGINEERED MUTATION SEQADV 7T0S ASN A 84 UNP P41182 CYS 84 ENGINEERED MUTATION SEQADV 7T0S GLY B 3 UNP P41182 EXPRESSION TAG SEQADV 7T0S SER B 4 UNP P41182 EXPRESSION TAG SEQADV 7T0S GLN B 8 UNP P41182 CYS 8 ENGINEERED MUTATION SEQADV 7T0S ARG B 67 UNP P41182 CYS 67 ENGINEERED MUTATION SEQADV 7T0S ASN B 84 UNP P41182 CYS 84 ENGINEERED MUTATION SEQADV 7T0S GLY C 3 UNP P41182 EXPRESSION TAG SEQADV 7T0S SER C 4 UNP P41182 EXPRESSION TAG SEQADV 7T0S GLN C 8 UNP P41182 CYS 8 ENGINEERED MUTATION SEQADV 7T0S ARG C 67 UNP P41182 CYS 67 ENGINEERED MUTATION SEQADV 7T0S ASN C 84 UNP P41182 CYS 84 ENGINEERED MUTATION SEQRES 1 A 127 GLY SER ALA ASP SER GLN ILE GLN PHE THR ARG HIS ALA SEQRES 2 A 127 SER ASP VAL LEU LEU ASN LEU ASN ARG LEU ARG SER ARG SEQRES 3 A 127 ASP ILE LEU THR ASP VAL VAL ILE VAL VAL SER ARG GLU SEQRES 4 A 127 GLN PHE ARG ALA HIS LYS THR VAL LEU MET ALA CYS SER SEQRES 5 A 127 GLY LEU PHE TYR SER ILE PHE THR ASP GLN LEU LYS ARG SEQRES 6 A 127 ASN LEU SER VAL ILE ASN LEU ASP PRO GLU ILE ASN PRO SEQRES 7 A 127 GLU GLY PHE ASN ILE LEU LEU ASP PHE MET TYR THR SER SEQRES 8 A 127 ARG LEU ASN LEU ARG GLU GLY ASN ILE MET ALA VAL MET SEQRES 9 A 127 ALA THR ALA MET TYR LEU GLN MET GLU HIS VAL VAL ASP SEQRES 10 A 127 THR CYS ARG LYS PHE ILE LYS ALA SER GLU SEQRES 1 B 127 GLY SER ALA ASP SER GLN ILE GLN PHE THR ARG HIS ALA SEQRES 2 B 127 SER ASP VAL LEU LEU ASN LEU ASN ARG LEU ARG SER ARG SEQRES 3 B 127 ASP ILE LEU THR ASP VAL VAL ILE VAL VAL SER ARG GLU SEQRES 4 B 127 GLN PHE ARG ALA HIS LYS THR VAL LEU MET ALA CYS SER SEQRES 5 B 127 GLY LEU PHE TYR SER ILE PHE THR ASP GLN LEU LYS ARG SEQRES 6 B 127 ASN LEU SER VAL ILE ASN LEU ASP PRO GLU ILE ASN PRO SEQRES 7 B 127 GLU GLY PHE ASN ILE LEU LEU ASP PHE MET TYR THR SER SEQRES 8 B 127 ARG LEU ASN LEU ARG GLU GLY ASN ILE MET ALA VAL MET SEQRES 9 B 127 ALA THR ALA MET TYR LEU GLN MET GLU HIS VAL VAL ASP SEQRES 10 B 127 THR CYS ARG LYS PHE ILE LYS ALA SER GLU SEQRES 1 C 127 GLY SER ALA ASP SER GLN ILE GLN PHE THR ARG HIS ALA SEQRES 2 C 127 SER ASP VAL LEU LEU ASN LEU ASN ARG LEU ARG SER ARG SEQRES 3 C 127 ASP ILE LEU THR ASP VAL VAL ILE VAL VAL SER ARG GLU SEQRES 4 C 127 GLN PHE ARG ALA HIS LYS THR VAL LEU MET ALA CYS SER SEQRES 5 C 127 GLY LEU PHE TYR SER ILE PHE THR ASP GLN LEU LYS ARG SEQRES 6 C 127 ASN LEU SER VAL ILE ASN LEU ASP PRO GLU ILE ASN PRO SEQRES 7 C 127 GLU GLY PHE ASN ILE LEU LEU ASP PHE MET TYR THR SER SEQRES 8 C 127 ARG LEU ASN LEU ARG GLU GLY ASN ILE MET ALA VAL MET SEQRES 9 C 127 ALA THR ALA MET TYR LEU GLN MET GLU HIS VAL VAL ASP SEQRES 10 C 127 THR CYS ARG LYS PHE ILE LYS ALA SER GLU HET E2E A 201 62 HET GOL A 202 14 HET CL A 203 1 HET E2E B 201 124 HET GOL B 202 14 HET E2E C 201 62 HETNAM E2E 3-CHLORO-5-{1-[2-({5-CHLORO-2-[(3S)-3-METHYLMORPHOLIN- HETNAM 2 E2E 4-YL]PYRIDIN-4-YL}AMINO)-2-OXOETHYL]-4-FLUORO-1H- HETNAM 3 E2E PYRROLO[2,3-B]PYRIDIN-3-YL}-2-HYDROXYBENZAMIDE HETNAM GOL GLYCEROL HETNAM CL CHLORIDE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 E2E 3(C26 H23 CL2 F N6 O4) FORMUL 5 GOL 2(C3 H8 O3) FORMUL 6 CL CL 1- FORMUL 10 HOH *178(H2 O) HELIX 1 AA1 ARG A 13 ARG A 28 1 16 HELIX 2 AA2 HIS A 46 SER A 54 1 9 HELIX 3 AA3 SER A 54 ASP A 63 1 10 HELIX 4 AA4 ASN A 79 SER A 93 1 15 HELIX 5 AA5 ASN A 101 LEU A 112 1 12 HELIX 6 AA6 MET A 114 LYS A 126 1 13 HELIX 7 AA7 ARG B 13 ARG B 28 1 16 HELIX 8 AA8 HIS B 46 SER B 54 1 9 HELIX 9 AA9 SER B 54 ASP B 63 1 10 HELIX 10 AB1 ASN B 79 SER B 93 1 15 HELIX 11 AB2 ASN B 101 GLN B 113 1 13 HELIX 12 AB3 MET B 114 ALA B 127 1 14 HELIX 13 AB4 ARG C 13 ARG C 28 1 16 HELIX 14 AB5 HIS C 46 SER C 54 1 9 HELIX 15 AB6 SER C 54 ASP C 63 1 10 HELIX 16 AB7 ASN C 79 SER C 93 1 15 HELIX 17 AB8 ASN C 101 LEU C 112 1 12 HELIX 18 AB9 MET C 114 ALA C 127 1 14 SHEET 1 AA1 3 GLU A 41 ALA A 45 0 SHEET 2 AA1 3 VAL A 34 VAL A 38 -1 N VAL A 38 O GLU A 41 SHEET 3 AA1 3 VAL A 71 ASN A 73 1 O ILE A 72 N VAL A 35 SHEET 1 AA2 2 GLN B 8 GLN B 10 0 SHEET 2 AA2 2 ARG C 94 ASN C 96 -1 O LEU C 95 N ILE B 9 SHEET 1 AA3 3 GLU B 41 ALA B 45 0 SHEET 2 AA3 3 VAL B 34 VAL B 38 -1 N ILE B 36 O PHE B 43 SHEET 3 AA3 3 VAL B 71 ASN B 73 1 O ILE B 72 N VAL B 37 SHEET 1 AA4 2 ARG B 94 ASN B 96 0 SHEET 2 AA4 2 GLN C 8 GLN C 10 -1 O ILE C 9 N LEU B 95 SHEET 1 AA5 3 GLU C 41 ALA C 45 0 SHEET 2 AA5 3 VAL C 34 VAL C 38 -1 N ILE C 36 O PHE C 43 SHEET 3 AA5 3 VAL C 71 ASN C 73 1 O ILE C 72 N VAL C 37 CRYST1 92.740 72.290 55.330 90.00 108.32 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010783 0.000000 0.003570 0.00000 SCALE2 0.000000 0.013833 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019038 0.00000